Jun. 24 at 4:44 PM
Let's hope
$SPRO &
$GSK lose out on there "next phase of growth" for not acting swiftly and boldly.
There is already a clean, willing and able cash shell
$FULC in Cambridge with
$300 million + cash.
FULC was a sickle cell disease failure (unfortunately) but at least the Board MOVES quickly. -- cut 85% of staff; put in retention bonuses for remaining management/employees, cut burn rate drastically, all to drive a reverse merger.
Shit is happening in Cambridge, MA.
